West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 89,800 | 492,700 | 362,600 | 226,600 | 115,300 |
| Depreciation Amortization | 40,000 | 155,400 | 114,700 | 74,500 | 35,600 |
| Income taxes - deferred | N/A | -3,500 | N/A | N/A | N/A |
| Accounts receivable | N/A | -58,800 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | 2,900 | N/A | N/A | N/A |
| Other Working Capital | 100 | 2,900 | -20,600 | -20,500 | -34,600 |
| Other Operating Activity | -500 | 61,800 | 6,600 | 2,600 | 1,900 |
| Operating Cash Flow | $129,400 | $653,400 | $463,300 | $283,200 | $118,200 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -71,300 | -377,000 | -272,100 | -190,800 | -90,600 |
| Other Investing Activity | 0 | -1,700 | -1,800 | -1,000 | 0 |
| Investing Cash Flow | $-71,300 | $-378,700 | $-273,900 | $-191,800 | $-90,600 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 164,700 | 164,700 | 35,000 | N/A |
| Debt Repayment | -200 | -192,300 | -192,200 | -59,000 | -700 |
| Common Stock Issued | 4,400 | 32,700 | 29,600 | 23,600 | 16,800 |
| Common Stock Repurchased | -136,000 | -566,600 | -512,000 | -459,600 | -272,400 |
| Dividend Paid | -15,200 | -59,100 | -43,800 | -29,300 | -14,700 |
| Other Financing Activity | 0 | -2,000 | 0 | 0 | 0 |
| Financing Cash Flow | $-147,000 | $-622,600 | $-553,700 | $-489,300 | $-271,000 |
| Exchange Rate Effect | 8,500 | -21,400 | 1,300 | -9,800 | -8,700 |
| Beginning Cash Position | 484,600 | 853,900 | 853,900 | 853,900 | 853,900 |
| End Cash Position | 404,200 | 484,600 | 490,900 | 446,200 | 601,800 |
| Net Cash Flow | $-80,400 | $-369,300 | $-363,000 | $-407,700 | $-252,100 |
| Free Cash Flow | |||||
| Operating Cash Flow | 129,400 | 653,400 | 463,300 | 283,200 | 118,200 |
| Capital Expenditure | -71,300 | -377,000 | -272,100 | -190,800 | -90,600 |
| Free Cash Flow | 58,100 | 276,400 | 191,200 | 92,400 | 27,600 |